- Company
SR Score
428
SR Web
450
ZyStor Therapeutics, Inc. is a privately-held biotechnology company developing enzyme replacement therapies for the treatment of lysosomal
Acquired by BioMarin Pharmaceutical on August 18, 2010
Website: https://www.zystor.com
Founded: January 01, 2004
Social: